Projected Market Size (2034): USD 1,42,406 Million
CAGR (2024-2034): 13.6%
Pricing Analysis:
Price Growth
Regional Variations
Market Historic Sales
Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
Analysis of revenue contributions from different manufacturers in the market.
Proteomics Market Definition
Proteomics can be defined as the method by which proteins associated with diseases are discovered and how their synthesis, roles, and structure are examined. Proteomic data is also employed to recognise prognostic indicators and make diagnoses of cancer, infectious diseases, malaria, and tuberculosis. Proteomics is used in the pharmaceutical sub-sector to determine the mode of action or toxicity of a particular drug. They are also used in the determination and validation of the biomarker efficiency as well.
The role of chronic and infectious diseases, the demand for faster & enhanced diagnostic techniques in the target diseases, and the role of personalized medicines. Furthermore, technological trends in protein analysis enhance the expansion of the protein industry are some of the factors contributing to proteomics market growth. However, the proteomics market has a high degree of growth propelled by technological development in the field of mass spectrometry and next-generation sequencing technology.
As documented in Nature Communications in July 2024, scientists used a proteomics-based approach to identify effectors secreted by Rickettsia spp and therefore explain the host-pathogen interface.
Download
Actionable Solutions
